Deerland Probiotics and Enzymes Revenue and Competitors
Estimated Revenue & Valuation
- Deerland Probiotics and Enzymes's estimated annual revenue is currently $47.5M per year.
- Deerland Probiotics and Enzymes's estimated revenue per employee is $297,000
Employee Data
- Deerland Probiotics and Enzymes has 160 Employees.
- Deerland Probiotics and Enzymes grew their employee count by -15% last year.
Deerland Probiotics and Enzymes's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Product Development & Procurement | Reveal Email/Phone |
2 | VP Marketing & Strategy | Reveal Email/Phone |
3 | VP, Human Resources | Reveal Email/Phone |
4 | Director Global Strategic Accounts | Reveal Email/Phone |
5 | Procurement Manager | Reveal Email/Phone |
Deerland Probiotics and Enzymes Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $47.5M | 160 | -15% | N/A | N/A |
#2 | $394.6M | 1044 | 5% | N/A | N/A |
What Is Deerland Probiotics and Enzymes?
Deerland Probiotics & Enzymes, based in Kennesaw, Ga., specializes in customized enzyme and probiotic-based formulations, collaborating with customers to develop innovative and often proprietary solutions. In addition to customized formulations, the company offers a line of clinically studied branded products, including the probiotic strain DE111® and novel prebiotic PreforPro®. Deerland provides regulatory support and also performs specialty contract manufacturing services, including bulk blends, liquids, hard shell capsules, and tablets; as well as bottling and labeling. To contact Deerland Probiotics & Enzymes, call 800.697.8179 or visit www.Deerland.com.
keywords:N/A
N/A
Total Funding
160
Number of Employees
$47.5M
Revenue (est)
-15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Kennesaw
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $26.5M | 166 | 8% | N/A |
#2 | $33.3M | 168 | 34% | N/A |
#3 | $63.5M | 175 | -2% | N/A |
#4 | $40.4M | 175 | -4% | N/A |
#5 | $28.2M | 177 | -4% | N/A |